Literature DB >> 3148066

Use of platelets, mononuclear and polymorphonuclear cells in the diagnosis of glycogen storage disease type VI.

N Dahan1, C Baussan, N Moatti, A Lemonnier.   

Abstract

We determined glycogen concentration and phosphorylase 'a+b' and phosphorylase a activities in platelets, mononuclear and polymorphonuclear cells from control subjects and patients with phosphorylase kinase deficiency (glycogen storage disease IX) and liver phosphorylase deficiency (glycogen storage disease VI). Variations according to cellular type and to subjects' age (1-40 years) were established. Variable glycogen overloading was found in all our patients. Glycogen storage disease (GSD) VI was characterized by a diminished total phosphorylase activity with a low or normal a/(a+b) ratio of phosphorylase activity. GSD IX was characterized by a very low residual activity of phosphorylase a with an 'a+b' activity low or normal.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3148066     DOI: 10.1007/bf01800366

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  16 in total

1.  Phosphorylase activity in leucocytes from patients with glycogen-storages disease.

Authors:  W C HULSMANN; T L OEI
Journal:  Lancet       Date:  1961-09-09       Impact factor: 79.321

2.  Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen-storage disease. A study of phosphorylase kinase deficiency.

Authors:  B Lederer; F Van Hoof; G Van den Berghe; H Hers
Journal:  Biochem J       Date:  1975-04       Impact factor: 3.857

3.  The stimulation of liver phosphorylase b by AMP, fluoride and sulfate. A technical note on the specific determination of the a and b forms of liver glycogen phosphorylase.

Authors:  W Stalmans; H G Hers
Journal:  Eur J Biochem       Date:  1975-06

4.  [Heterogeneity of glycogenosis type VI. Study of leukocyte phosphorylase activity in 2 families].

Authors:  P Guibaud; M Mathieu
Journal:  Arch Fr Pediatr       Date:  1972-12

5.  Hepatic phosphorylase deficiency: a biochemical study.

Authors:  J F Koster; J Fernandes; R G Slee; T J van Berkel; W C Hülsmann
Journal:  Biochem Biophys Res Commun       Date:  1973-07-02       Impact factor: 3.575

6.  Liver glycogen phosphorylase deficiency.

Authors:  G I Drummond; D F Hardwick; S Israels
Journal:  Can Med Assoc J       Date:  1970-04-11       Impact factor: 8.262

7.  Hepatic glycogenosis due to phosphorylase deficiency. Limitations of enzyme studies on liver biopsy specimens.

Authors:  R Wagner; F Huijing; E Porter
Journal:  Am J Med       Date:  1971-11       Impact factor: 4.965

8.  Liver glycogenosis caused by a defective phosphorylase system: hemolysate analysis.

Authors:  C Baussan; N Moatti; M Odievre; A Lemonnier
Journal:  Pediatrics       Date:  1981-01       Impact factor: 7.124

9.  Glycogen in leukocytes from patients with hepatic encephalopathy.

Authors:  S Yokoi; N Amano
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

10.  Enzyme activities in blood cells of man and dogs after separation on a discontinuous Percoll gradient.

Authors:  J Lindena; U Sommerfeld; C Höpfel; R Wolkersdorfer; I Trautschold
Journal:  Enzyme       Date:  1983
View more
  2 in total

1.  Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI.

Authors:  B Burwinkel; H D Bakker; E Herschkovitz; S W Moses; Y S Shin; M W Kilimann
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

Review 2.  Fatal infantile hypertrophic cardiomyopathy secondary to deficiency of heart specific phosphorylase b kinase.

Authors:  M Elleder; Y S Shin; A Zuntová; P Vojtovic; V Chalupecký
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.